Letter: limitations of studies to evaluate the significance of anti-tumour necrosis factor serum levels in Crohn's disease

被引：2

作者：

Chaparro, M. ^{[1
]}

Gisbert, J. P. ^{[1
]}

机构：

[1] Hosp Univ La Princesa, Inst Invest Sanitaria Princesa IP, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain

来源：

ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2014年 / 40卷 / 01期

关键词：

INFLIXIMAB;

D O I：

10.1111/apt.12799

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

引用

页码：120 / 121

页数：3

共 8 条

[1]

CORRELATIONS BETWEEN CLINICAL ACTIVITY, ENDOSCOPIC SEVERITY, AND BIOLOGICAL PARAMETERS IN COLONIC OR ILEOCOLONIC CROHNS-DISEASE - A PROSPECTIVE MULTICENTER STUDY OF 121 CASES [J].

CELLIER, C ;

SAHMOUD, T ;

FROGUEL, E ;

ADENIS, A ;

BELAICHE, J ;

BRETAGNE, JF ;

FLORENT, C ;

BOUVRY, M ;

MARY, JY ;

MODIGLIANI, R ;

COLOMBEL, JF ;

CORTOT, A ;

LESCUT, D ;

BITOUN, A ;

LEMANN, M ;

SALMERON, M ;

THEROND, JP ;

VERNISSE, B ;

SEE, A ;

RAOUL, JL .

GUT, 1994, 35 (02) :231-235

[2]

A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease [J].

Levesque, B. G. ;

Greenberg, G. R. ;

Zou, G. ;

Sandborn, W. J. ;

Singh, S. ;

Hauenstein, S. ;

Ohrmund, L. ;

Wong, C. J. ;

Stitt, L. W. ;

Shackelton, L. M. ;

King, D. ;

Lockton, S. ;

Ducharme, J. ;

Feagan, B. G. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) :1126-1135

[3]

Lobaton Triana, 2013, J Crohns Colitis, V7, pe641, DOI 10.1016/j.crohns.2013.05.005

[4]

Miranda Garcia P, 2012, J CROHNS COLITIS S, Vs61, pP104

[5]

Evaluation of the concordance between biological markers and clinical activity in inflammatory bowel disease [J].

Miranda Garcia, Pablo ;

Chaparro, Maria ;

Gisbert, Javier P. .

MEDICINA CLINICA, 2015, 144 (01) :9-13

[6]

Papamichael Konstantinos, 2013, J Crohns Colitis, V7, pe700, DOI 10.1016/j.crohns.2013.07.008

[7]

The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab [J].

Ungar, Bella ;

Chowers, Yehuda ;

Yavzori, Miri ;

Picard, Orit ;

Fudim, Ella ;

Har-Noy, Ofir ;

Kopylov, Uri ;

Eliakim, Rami ;

Ben-Horin, Shomron .

GUT, 2014, 63 (08) :1258-1264

[8]

Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient [J].

Vande Casteele, Niels ;

Gils, Ann ;

Singh, Sharat ;

Ohrmund, Linda ;

Hauenstein, Scott ;

Rutgeerts, Paul ;

Vermeire, Severine .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (06) :962-971

← 1 →